BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4171584)

  • 21. Acute myocardial infarction, hyperglycemia, and insulin.
    Dandona P; Chaudhuri A; Ghanim H
    J Am Coll Cardiol; 2009 Apr; 53(16):1437-9. PubMed ID: 19371827
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucose-insulin-potassium therapy for acute myocardial infarction: what goes around comes around.
    Gnaim CI; McGuire DK
    Am Heart J; 2004 Dec; 148(6):924-30. PubMed ID: 15632873
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of refractory cardiac insufficiency with infusion of glucagon, insulin, glucose and potassium].
    Castaldi C; D'Amore F; Materia E; Mauceri M; Rivosecchi L
    Minerva Cardioangiol; 1978 Nov; 26(11):751-6. PubMed ID: 724124
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucose-insulin-potassium-albumin infusion in the early phase of acute myocardial infarction--a controlled study.
    Sundstedt CD; Sylvén C; Mogensen L
    Acta Med Scand; 1981; 210(1-2):67-71. PubMed ID: 7027747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction.
    Heng MK; Norris RM; Singh BN; Barratt-Boyes C
    Br Heart J; 1977 Jul; 39(7):748-57. PubMed ID: 328028
    [No Abstract]   [Full Text] [Related]  

  • 26. The glucose-insulin-potassium (GIK) regimen in the treatment of myocardial ischemia.
    Brachfeld N
    Circulation; 1973 Sep; 48(3):459-62. PubMed ID: 4726230
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of "polarizing" solutions (glucose, potassium, insulin) in acute coronary insufficiency. Review of the literature and the authors' data].
    Chernov AZ; Gerchikova TN
    Ter Arkh; 1969 Nov; 41(11):8-13. PubMed ID: 4916348
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction.
    Whitlow PL; Rogers WJ; Smith LR; McDaniel HG; Papapietro SE; Mantle JA; Logic JR; Russell RO; Rackley CE
    Am J Cardiol; 1982 Mar; 49(4):811-20. PubMed ID: 7039286
    [No Abstract]   [Full Text] [Related]  

  • 29. Potassium, glucose, and insulin in treatment of heart block after myocardial infarction.
    Mittra B
    Lancet; 1966 Dec; 2(7479):1438-41. PubMed ID: 4163442
    [No Abstract]   [Full Text] [Related]  

  • 30. Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the Glucose-Insulin-Potassium Study (GIPS)-II.
    Timmer JR; Svilaas T; Ottervanger JP; Henriques JP; Dambrink JH; van den Broek SA; van der Horst IC; Zijlstra F
    J Am Coll Cardiol; 2006 Apr; 47(8):1730-1. PubMed ID: 16631017
    [No Abstract]   [Full Text] [Related]  

  • 31. Group 3. Observations on 400 cases of acute myocardial infarction treated with Insulin, Potassium and Dextrose infusions.
    Lal HB; Caroli RK
    Indian J Med Res; 1968 Jul; 56(7 Suppl):1120-36. PubMed ID: 5006821
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of glucose-insulin-potassium infusion on the human conduction system.
    Gould L; Reddy CV; Gomprecht RF
    Am J Cardiol; 1974 Apr; 33(4):498-506. PubMed ID: 4818048
    [No Abstract]   [Full Text] [Related]  

  • 33. The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction.
    Bedetti G; Pizzi C; Gabrieli L; Varga A; Pasanisi E; Bugiardini R; Picano E
    Int J Cardiol; 2005 Jul; 102(2):255-8. PubMed ID: 15982493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Apstein CS
    JAMA; 2005 Jun; 293(21):2596-7; author reply 2598. PubMed ID: 15928276
    [No Abstract]   [Full Text] [Related]  

  • 35. Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial.
    Apstein CS; Taegtmeyer H
    Circulation; 1997 Aug; 96(4):1074-7. PubMed ID: 9286931
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical unspecificity and metabolic specificity of the polarizing solution (author's transl)].
    Sodi-Pallarés D
    Folia Clin Int (Barc); 1976 Jan; 26(1):7-13. PubMed ID: 789132
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).
    van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Gans RO; de Boer MJ; Zijlstra F;
    Am Heart J; 2005 Apr; 149(4):585-91. PubMed ID: 15990738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, tolerability, and efficacy of a glucose-insulin-potassium-magnesium-carnitine solution in acute myocardial infarction.
    Arsenian MA; New PS; Cafasso CM
    Am J Cardiol; 1996 Aug; 78(4):477-9. PubMed ID: 8752197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Dey J; Blonde L; Burshell A; Bolton P; Richard A
    JAMA; 2005 Jun; 293(21):2597-8; author reply 2598. PubMed ID: 15928277
    [No Abstract]   [Full Text] [Related]  

  • 40. [Status of glucose-insulin-potassium solutions in acute myocardial infarct].
    Artese D; Albani A; Di Nicola A
    Clin Ter; 1985 Jun; 113(6):457-65. PubMed ID: 3896620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.